Previous studies indicated that signal transductions of cell-surface receptor pathways were inhibited by EGCG in MDA-MB-231 human breast cancer cells, contributing to the reduced production of vascular endothelial growth factor (VEGF) [33,34]. Here, VEGFA is linked to breast cancer.